Vitrafy Life Sciences (ASX:VFY) said its non-underwritten share purchase plan targeting proceeds of about AU$2 million is now open and will run until July 3, according to a Friday filing with the Australian bourse.
The plan is open to shareholders of record as of June 11 at a price of AU$2.60 per share.
The company's shares rose past 1% in recent Friday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.